If you got a question, look no further.
We post the most common questions
in our FAQ section.
Please fill in the form below to receive a Free Sample of the Report.
SummaryNanoString Technologies Inc (NanoString) is a provider of life science products and tools for translational research and molecular diagnostics. The company's products portfolio includes sprint profiler, Dx analysis system with flex, MAX analysis system, protein assays, solid tumor assays, gene fusion panels, RNA panels, DNA assays, immunology panel, gene expression codesets, pancancer immune profiling and pathways among others. NanoString's nCounter analysis system provides cost-effective method to profile hundreds of miRNA, miRGE or DNA molecules simultaneously employing digital molecular barcoding technology. The company sells its products through direct sales force and distributors in the US, Europe, the Middle East and Asia-Pacific. NanoString is headquartered in Seattle, Washington, the US.This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.Scope:- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments- The report analyzes all pipeline products in development for the company NanoString Technologies Inc- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date- The report provides detailed description of products in development, technical specification and functions- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.Reasons to Buy:- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio- To formulate effective Research & Development strategies- Develop market-entry and market expansion strategies- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of ContentsTable of Contents 2List of Tables 4List of Figures 4NanoString Technologies Inc Company Overview 5NanoString Technologies Inc Company Snapshot 5NanoString Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview 5NanoString Technologies Inc - Pipeline Analysis Overview 8NanoString Technologies Inc - Key Facts 8NanoString Technologies Inc - Major Products and Services 9NanoString Technologies Inc Pipeline Products by Development Stage 10NanoString Technologies Inc Pipeline Products Overview 12Advanced Gene Expression Assay 12Advanced Gene Expression Assay Product Overview 12Companion Diagnostic Assay - Diffuse Large B-Cell Lymphoma (DLBCL) 13Companion Diagnostic Assay - Diffuse Large B-Cell Lymphoma (DLBCL) Product Overview 13Companion Diagnostic Test - Enzalutamide 14Companion Diagnostic Test - Enzalutamide Product Overview 14Digital Immunohistochemistry Device 15Digital Immunohistochemistry Device Product Overview 15Immune-Related Gene Expression Assay 16Immune-Related Gene Expression Assay Product Overview 16In Vitro Diagnostic Assay - HCC Gene Signature 17In Vitro Diagnostic Assay - HCC Gene Signature Product Overview 17Multi-Omic Assay 18Multi-Omic Assay Product Overview 18nCounter Vantage DNA Solid Tumor Panel 19nCounter Vantage DNA Solid Tumor Panel Product Overview 19nCounter Vantage RNA:Protein Solid Tumor Pathways Panel 20nCounter Vantage RNA:Protein Solid Tumor Pathways Panel Product Overview 20NanoString Technologies Inc - Key Competitors 21NanoString Technologies Inc - Key Employees 22NanoString Technologies Inc - Locations And Subsidiaries 23Head Office 23Recent Developments 24NanoString Technologies Inc, Recent Developments 24May 04, 2017: NanoString Technologies Releases Operating Results for First Quarter of 2017 24Apr 03, 2017: Digital Spatial Profiling Technology Enables Quantitative Protein Profiling in FFPE Tissue Providing Detailed Molecular Characterization of Immune Response to Tumors 25Mar 23, 2017: NanoString Launches New PlexSet Technology as an Alternative to qPCR for Multiplexed High-Throughput Gene Expression Studies 26Mar 01, 2017: NanoString Technologies Releases Fourth Quarter and Full Year 2016 Operating Results and Provides 2017 Outlook 27Jan 31, 2017: Humana Issues Positive Coverage Decision for NanoString's Prosigna Breast Cancer Assay 28Jan 10, 2017: NanoString Technologies Provides Preliminary Operational and Financial Results for 2016 29Jan 10, 2017: Blue Cross Blue Shield Association Evidence Street Issues Positive Assessment for NanoString's Prosigna Breast Cancer Assay 29Dec 12, 2016: Prosigna Breast Cancer Assay Outperforms All Other Commercial Assays Tested in Updated Analysis of TransATAC Study Presented at the 39th Annual CTRC-AACR San Antonio Breast Cancer Symposium 30Dec 05, 2016: NanoString Technologies Highlights Presentation of Multiple Prosigna/PAM50 and Immuno-Oncology Studies at the 39th Annual CTRC-AACR San Antonio Breast Cancer Symposium 32Nov 18, 2016: NanoString Enhances Solid Tumor Profiling with 3D Biology Capabilities for Formalin-Fixed, Paraffin-Embedded (FFPE) Tissue Samples 35Appendix 36Methodology 36About GlobalData 38Contact Us 38Disclaimer 38List of TablesNanoString Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview 5NanoString Technologies Inc Pipeline Products by Equipment Type 6NanoString Technologies Inc Pipeline Products by Indication 7NanoString Technologies Inc, Key Facts 8NanoString Technologies Inc, Major Products and Services 9NanoString Technologies Inc Number of Pipeline Products by Development Stage 10NanoString Technologies Inc Pipeline Products Summary by Development Stage 11Advanced Gene Expression Assay - Product Status 12Advanced Gene Expression Assay - Product Description 12Companion Diagnostic Assay - Diffuse Large B-Cell Lymphoma (DLBCL) - Product Status 13Companion Diagnostic Assay - Diffuse Large B-Cell Lymphoma (DLBCL) - Product Description 13Companion Diagnostic Test - Enzalutamide - Product Status 14Companion Diagnostic Test - Enzalutamide - Product Description 14Digital Immunohistochemistry Device - Product Status 15Digital Immunohistochemistry Device - Product Description 15Immune-Related Gene Expression Assay - Product Status 16Immune-Related Gene Expression Assay - Product Description 16In Vitro Diagnostic Assay - HCC Gene Signature - Product Status 17In Vitro Diagnostic Assay - HCC Gene Signature - Product Description 17Multi-Omic Assay - Product Status 18Multi-Omic Assay - Product Description 18nCounter Vantage DNA Solid Tumor Panel - Product Status 19nCounter Vantage DNA Solid Tumor Panel - Product Description 19nCounter Vantage RNA:Protein Solid Tumor Pathways Panel - Product Status 20nCounter Vantage RNA:Protein Solid Tumor Pathways Panel - Product Description 20NanoString Technologies Inc, Key Employees 22Glossary 37List of FiguresNanoString Technologies Inc Pipeline Products by Equipment Type 6NanoString Technologies Inc Pipeline Products by Development Stage 10